Technology

Serena Williams and Beth Ferreira Launch Starfire Ventures With a $200 Million Fund Target

Martin HollowayPublished 6m ago3 min readBased on 2 sources
Reading level
Serena Williams and Beth Ferreira Launch Starfire Ventures With a $200 Million Fund Target
Photo by Doha Stadium Plus Qatar from Doha, Qatar / CC BY 2.0

Serena Williams and Beth Ferreira have launched Starfire Ventures, an early-stage investment firm, and are seeking to raise a $200 million debut fund, according to TechCrunch, published 16 November 2026.

The firm says it will back AI-native companies, meaning businesses whose core product is built around machine learning models rather than having AI added afterward. Those companies should address critical, underserved problems for individuals across the experience economy, a term for consumer spending on services, leisure and personal experiences. Named sectors include fintech and health and wellness. The fund is a target, not a closed vehicle, so the size of eventual commitments is still an open question.

Starfire is a separate entity from Serena Ventures, the firm Williams founded in 2022. According to TechCrunch, Serena Ventures has cut its last check but retains a team to support its existing portfolio. Over its life, that firm backed more than 100 companies and raised over $100 million in capital. Ferreira worked at Serena Ventures as an advisor and general partner.

The two have invested together since 2015, when they backed the seed round of MasterClass, a consumer education platform. That early bet is a useful reference point: a high-profile operator and an experienced investor backing a product category before it became crowded.

The broader context here is familiar to venture watchers. Celebrity-led funds have often struggled to separate the operator's brand from the fund's returns. A $200 million debut fund is also demanding to build, because the firm must create a track record while competing for allocation with established early-stage managers. Whether the AI-native thesis produces a real sourcing advantage, rather than a label on a conventional consumer portfolio, will become visible in the company list over several investment cycles.

In my view, the more interesting question is what the thesis means for the companies receiving the money. Fintech and health and wellness are areas where individual users face real, recurring problems, and where model-driven products can be measured against outcomes such as adherence, approval rates or time saved. Both sectors also carry heavy regulatory exposure and sensitive data, so founders will need to address those constraints from the first product decision. An investor with a consumer focus can help with distribution and early customer feedback, which matters most where trust is slow to build.

The launch also clarifies how the partners have structured their next phase. Rather than extending the earlier firm, they started a new entity with a new mandate, leaving the existing portfolio with a dedicated team. For founders in that portfolio, the practical effect is continuity of support. For the market, the $200 million target and the first disclosed investments are the figures to track.